Award

Klevit pushing ‘physical techniques to their limits’

The University of Washington scientist won the ASBMB's 2015 Fritz Lipmann Lectureship
Maggie Kuo
March 01, 2015

Rachel E. Klevit, professor of biochemistry at University of Washington, will give the Fritz Lipmann Lecture at the 2015 American Society for Biochemistry and Molecular Biology annual meeting. The society issues the award every two years to recognize researchers who’ve contributed conceptual advances in biochemistry, bioenergetics or molecular biology.

Klevit-web.jpg "It’s a special honor to be recognized by ASBMB with a Fritz Lipmann Award. One of my guiding principles is to apply chemical concepts and intuitions to understand biology, and this practice led Lipmann to his groundbreaking and seminal contributions. When teaching undergraduate students, I encourage them to think conceptually rather than learn by rote. The many talented students, postdoctoral fellows, collaborators and colleagues with whom I have had the pleasure to associate over the years have provided a fertile and fun environment in which to try to better understand how molecules make biology work. " — RACHEL E. KLEVIT

Klevit’s “research contributions have made a profound impact on the way we understand many very important aspects of biological chemistry,” writes Trisha N. Davis of University of Washington in her nomination letter. “Her research has been instrumental in understanding the mechanism of disease of two scourges, breast cancer and Parkinson’s. Moreover, she has changed the way research in this area is done.”

Klevit is recognized for innovatively using physical methods to determine the structure and function of proteins. Her most lauded contributions are using nuclear magnetic resonance spectroscopy to solve the structure of the Cys2-His2 zinc finger fold, a common motif present in many DNA-binding proteins, and defining the BRCA1-mediated ubiquitination system that is fundamental to the pathogenesis of breast cancer.

Klevit is considered a pioneer in using NMR to study ubiquitination enzymes. “Indeed, she is the unmatched leader in the analysis of ubiquitination by NMR,” writes Michael Rape of the University of California, Berkeley, in his letter of support. Along with her investigations of the BRCA1 enzyme, she recently discovered a new class of ubiquitination enzymes that has implications in understanding the development of Parkinson’s disease.

A defining characteristic of her approach is “a willingness to boldly push the biophysical methods to extract the most important biological insights from the system under study,” writes Lila M. Gierasch at the University of Massachusetts.

Besides her many significant scientific contributions, Klevit is known for her commitment to the scientific community and training young scientists. “Her graduate students are enthusiastic about science – they love working for her,” writes Rape. “Rachel is also most welcoming to young colleagues that have just entered her field, and she supports them heavily during their first hard years as principal investigators,” he continues. “These characteristics make Rachel one of the most cherished and important members of the ubiquitin community.”

Klevit has served on numerous study sections for the National Institutes of Health and the California Breast Cancer Program and was a member of the editorial board for the Journal of Biological Chemistry.

Klevit received her D. Phil. in chemistry from Oxford University in England. She did her postdoctoral training at Duke University Medical Center and University of Washington. She then joined the research faculty of the department of chemistry at University of Washington and later became professor of biochemistry there.

Maggie Kuo

Maggie Kuo was an intern at ASBMB Today when she wrote this story. Today she is a writer at the American Physiological Society. She earned her Ph.D. in biomedical engineering at Johns Hopkins University.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

Glycobiology society honors; NAI inducts Batzer; inspiring Latinx scientists
Member News

Glycobiology society honors; NAI inducts Batzer; inspiring Latinx scientists

September 28, 2020

Honors, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

Herbert Tabor 1918 – 2020
Retrospective

Herbert Tabor 1918 – 2020

September 24, 2020

F. Peter Guengerich remembers the contributions of the longtime editor of the Journal of Biological Chemistry who died in August.

ASBMB welcomes new members
Member News

ASBMB welcomes new members

September 21, 2020

The American Society for Biochemistry and Molecular biology welcomed more than 60 new members in April.

It all comes down to where we place our bets
Interview

It all comes down to where we place our bets

September 18, 2020

Mark Harpel works in a research unit at GlaxoSmithKline that helps choose the most promising targets for new drug development.

Understanding the impact of Type 1 diabetes susceptibility genes
Research Spotlight

Understanding the impact of Type 1 diabetes susceptibility genes

September 17, 2020

Starting in eighth grade, a series of mentors who saw something special in Sharifa Love–Rutledge helped her stay on the path to being a researcher — and becoming a mentor to others.

Cell biology, microbiology societies present awards
Member News

Cell biology, microbiology societies present awards

September 14, 2020

Honorees include ASBMB members Joann Trejo, James Olzmann, Steven Farber, Sue Wickner and Bernard Moss.